Zobrazeno 1 - 10 of 89 pro vyhledávání: '"J. De Vries-Bouwstra"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
POS0205 SAFETY AND TOLERABILITY OF NINTEDANIB IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES (ILDs) IN SUBGROUPS BY SEX AND AGE
Autor: A. M. Hoffmann-Vold, E. Volkmann, Y. Allanore, S. Assassi, J. de Vries-Bouwstra, V. Smith, I. Tschoepe, L. Loaiza, M. Kanakapura, O. Distler
Publikováno v: Annals of the Rheumatic Diseases. 81:338-339
BackgroundNintedanib slows the progression of fibrosing ILDs, with a safety profile characterised predominantly by gastrointestinal events.ObjectivesAssess the safety and tolerability of nintedanib in patients with autoimmune disease-related ILDs by
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e3ed18777b24ca9b3bc0df95fa143e19
https://doi.org/10.1136/annrheumdis-2022-eular.744
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
POS0916 A 10-YEAR JOURNEY OF CARING FOR PATIENTS WITH SYSTEMIC SCLEROSIS: FOLLOW-UP DATA ON DISEASE DURATION OF THE LEIDEN CCISS COHORT
Autor: S. Liem, S. Ahmed, J. Ciaffi, L. Beaart- van de Voorde, A. Schouffoer, J. Geelhoed, N. Ajmone-Marsan, T. Huizinga, J. De Vries-Bouwstra
Publikováno v: Annals of the Rheumatic Diseases. 81:758.1-758
BackgroundCombined Care in Systemic Sclerosis (CCISS) is a prospective cohort of patients referred to Leiden University Medical Center for Raynaud’s Phenomenon (RP), a suspicion of systemic sclerosis (SSc) or a connective tissue disease. This cohor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ceb7e8b6189e2555771c4a189f3130b
https://doi.org/10.1136/annrheumdis-2022-eular.4339
Zobrazit plný text záznamu
5
POS0865 THE EFFECT OF SILVER FIBER GLOVES ON RAYNAUD’S PHENOMENON IN PATIENTS WITH SYSTEMIC SCLEROSIS: A DOUBLE-BLIND RANDOMIZED CROSS-OVER TRIAL
Autor: S. Liem, E. Hoekstra, F. Bonte-Mineur, C. Magro Checa, A. Schouffoer, C. Allaart, T. Huizinga, S. A. Bergstra, J. De Vries-Bouwstra
Publikováno v: Annals of the Rheumatic Diseases. 81:726.2-727
BackgroundOver 90% of patients with systemic sclerosis (SSc) experience Raynaud’s phenomenon (RP), which strongly influences quality of life. Therapeutic options of RP include drug treatment and general lifestyle measures such as smoking cessation
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b4661d5bac1c8388f92ef7263b60f5d9
https://doi.org/10.1136/annrheumdis-2022-eular.1805
Zobrazit plný text záznamu
6
POS0469 ENDOTHELIAL TO MESENCHYMAL TRANSITION AND SENESCENCE ARE PART OF THE FIBROTIC PATHOGENESIS IN SYSTEMIC SCLEROSIS
Autor: Y. H. Chiu, J. Spierings, J. M. Van Laar, J. De Vries-Bouwstra, M. Van Dijk, R. Goldschmeding
Publikováno v: Annals of the Rheumatic Diseases. 81:488.3-489
BackgroundSystemic sclerosis (SSc) is a systemic autoimmune disease characterised by inflammation, vasculopathy and fibrosis. Several mechanisms, including endothelial to mesenchymal transition (EndMT) and cellular senescence, may be included in the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2c7d801429408804af3baae41d9ae363
https://doi.org/10.1136/annrheumdis-2022-eular.76
Zobrazit plný text záznamu
7
AB0675 Health related quality of life in patients with mixed connective tissue disease: A comparison with matched systemic sclerosis patients
Autor: I. Abouyahya, S. Liem, Z. Amoura, J. E. Fonseca, B. Chaigne, M. Cutolo, A. Doria, R. Fischer-Betz, V. Guimaraes, E. Hachulla, T. Huizinga, J. M. van Laar, T. Martin, M. Matucci-Cerinic, C. Montecucco, M. Schneider, V. Smith, A. Tincani, U. Müller-Ladner, J. de Vries-Bouwstra
Publikováno v: Annals of the Rheumatic Diseases. 81:1465.2-1465
BackgroundMixed connective tissue disease (MCTD) is a systemic auto-immune disorder, being probably the least common among the connective tissue diseases. Symptoms can be severe and could affect health-related quality of life (HRQoL). Identification
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c4132b90660b2f62f2c77d653b76bffa
https://doi.org/10.1136/annrheumdis-2022-eular.2359
Zobrazit plný text záznamu
8
POS0140 PREDICTING OUTCOMES IN SYSTEMIC SCLEROSIS: STRATIFICATION BY AUTO-ANTIBODIES OUTPERFORMS CUTANEOUS SUBSETTING IN THE EUSTAR COHORT
Autor: M. Elhai, M. Boubaya, N. Sritharan, A. Balbir-Gurman, E. Siegert, E. Hachulla, J. De Vries-Bouwstra, G. Riemekasten, J. H. W. Distler, D. Veale, E. Rosato, F. Del Galdo, F. A. Mendoza, D. Furst, C. De la Puente Bujidos, A. M. Hoffmann-Vold, A. Gabrielli, O. Distler, C. Bloch-Queyrat, Y. Allanore
Publikováno v: Annals of the Rheumatic Diseases. 81:297.1-297
BackgroundRisk-stratification is key in a heterogeneous disease like systemic sclerosis (SSc). Until now, SSc patients are stratified according to the extent of skin involvement into limited cutaneous, diffuse cutaneous and sine scleroderma subtypes.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa25e906980bbfba60122060bd80a09d
https://doi.org/10.1136/annrheumdis-2022-eular.1224
Zobrazit plný text záznamu
9
POS0383 CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS SINE SCLERODERMA: DATA FROM THE INTERNATIONAL EUSTAR DATABASE
Autor: A. Lescoat, S. Huang, P. Carreira, E. Siegert, J. De Vries-Bouwstra, J. H. W. Distler, V. Smith, F. Del Galdo, B. Anic, N. Damjanov, S. Rednic, C. Ribi, D. Farge, A. M. Hoffmann-Vold, A. Gabrielli, O. Distler, D. Khanna, Y. Allanore
Publikováno v: Annals of the Rheumatic Diseases. 81:446.1-446
BackgroundLeRoy’s classification defines two main subsets of Systemic Sclerosis (SSc) based on the extent of skin fibrosis: limited cutaneous SSc (lcSSc) with skin thickening sparing the trunk and distal to the elbow and knees, and diffuse cutaneou
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::471e02227505166377f5fb3591fb2b14
https://doi.org/10.1136/annrheumdis-2022-eular.3773
Zobrazit plný text záznamu
10
AB1236 CLINICAL CHARACTERISTICS OF JUVENILE ONSET SYSTEMIC SCLEROSIS PATIENTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT COMPARED TO ADULT AGE JUVENILE-ONSET PATIENTS FROM EUSTAR. ARE THESE DIFFERENCES SUGGESTING RISK FOR MORTALITY?
Autor: I. Foeldvari, J. Klotsche, P. Carreira, O. Kasapcopur, K. Torok, P. Airò, F. Iannone, Y. Allanore, A. Balbir-Gurman, T. Schmeiser, F. R. Sztajnbok, M. T. Terreri, V. Stanevicha, J. Anton, B. Feldman, R. Khubchandani, E. Alexeeva, S. Johnson, M. Katsikas, S. Sawhney, V. Smith, S. Appenzeller, T. Avcin, C. Campochiaro, J. De Vries-Bouwstra, M. Kostik, T. Lehman, E. Marrani, D. Schonenberg, W. A. Sifuentes-Giraldo, N. Vasquez-Canizares, M. Janarthanan, H. Malcova, M. Moll, D. Nemcova, A. Patwardhan, M. J. Santos, G. Seskute, M. E. Truchetet, C. Battagliotti, L. Berntson, B. Bica, J. Brunner, R. Cimaz, P. Costa Reis, D. Eleftheriou, L. Harel, G. Horneff, D. Kaiser, T. Kallinich, D. Lazarevic, K. Minden, S. Nielsen, F. Nuruzzaman, S. Opsahl Hetlevik, Y. Uziel, D. Veale, A. M. Hoffmann-Vold, A. Gabrielli, O. Distler
Publikováno v: Annals of the Rheumatic Diseases. 81:1729.2-1730
BackgroundJuvenile systemic sclerosis (jSSc) is an orphan autoimmune disease with a prevalence of 3 in 1 000 000 children. Information on long-term development of organ involvement and clinical characteristics of jSSc patients in adulthood are lackin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2079b50ebe8989bcc6b344d73eddbc99
https://doi.org/10.1136/annrheumdis-2022-eular.1531
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje